Clinical Trials Browser

Unknown × Interventional × IL32 protein, human × Clear all

NCT02809092 2019-10-15

Interleukin-21 (IL-21)- Expanded Natural Killer Cells for Induction of Acute Myeloid Leukemia

Phase 1/2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute